Roche Holding

ROP · SIX · CHF

CHF 349.00Change from previous close: −0.03%Absolute change: −CHF 0.10

Close · October 1, 2026

At a glance

Revenue growth
+1.54%
2025 vs 2024
Net income growth
+55.61%
2025 vs 2024
Net margin
20.3%
2024: 13.3%

Financial data

Amounts in millions of CHF; per-share values in CHF; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue63,35662,39560,44165,814—
Cost of revenue16,64516,28316,35719,737—
Gross profit46,71146,11244,08446,077—
Selling, general and administrative15,16114,89614,88114,201—
Research and development13,35215,30414,20015,225—
Operating income18,47613,41715,39517,476—
EBIT18,31913,19615,07617,017—
EBITDA21,70516,61918,54020,861—
Interest expense1,3461,403997690—
Pre-tax income16,97311,79314,07916,327—
Income tax3,1742,6061,7212,796—
Net income12,8808,27711,49812,421—
Net income to common shareholders12,8808,27711,49812,421—
Basic EPS16.1810.3914.4015.52—
Diluted EPS16.0410.3114.3115.37—
Average shares (basic)796797799800—
Average shares (diluted)803802804808—